Answers are grounded in this paper and cite their sources.
Human pluripotent stem cell-derived cardiomyocytes (hPSC-CM) represent a potential indefinite cell supply for cardiac tissue engineering and possibly regenerative medicine applications. However, hPSC-CMs produced by current protocols are not representative of native adult human cardiomyocytes as they display immature gene expression profile, structure and function. In order to improve hPSC-CM maturity and function, various approaches have been developed, including genetic manipulations to induce gene expression, delivery of biochemical factors such as triiodothyronine and alpha-adrenergic agonist phenylephrine, induction of cell alignment in 3D tissues, mechanical stress as a mimic of cardiac load and electrical stimulation/pacing or a combination of these. In this mini review, we discuss biomimetic strategies for the maturation for hPSC-CMs with a particular focus on electromechanical conditioning methods.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: